Follow the Harvest Health & Recreation INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Harvest Health & Recreation INC. has published 20 public disclosures. The latest transaction was reported on 5 October 2021 (Disposition). Among the most active insiders: Sailor Elroy. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
20 of 20 declarations
Harvest Health & Recreation Inc. (ticker: HRVSF) was a U.S.-based cannabis operator built around a vertically integrated “seed-to-sale” model spanning cultivation, processing, manufacturing, and retail distribution. Founded in 2011, the company expanded rapidly during the multi-state operator era by assembling licenses, dispensaries, and branded product capabilities across multiple regulated U.S. markets. At its peak, Harvest presented itself as one of the more established cannabis platforms in the United States, with a broad operational footprint and a strategy centered on control of the value chain and compliance in state-by-state regulated markets. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1760439/000156459021016712/hrvsf-10k_20201231.htm?utm_source=openai)) For international investors, it is important to note that Harvest Health & Recreation Inc. is a company from the United States, and HRVSF has been followed primarily as a U.S. cannabis equity rather than as a conventional NYSE/NASDAQ large-cap listing in the recent period. Its market profile was that of a small-cap, regulation-sensitive cannabis name, with valuation heavily influenced by licensing, cash access, state-level operating rules, and sector consolidation. The company’s competitive positioning historically came from vertical integration, local market licenses, and the ability to scale retail and branded offerings across several states. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1760439/000156459021016712/hrvsf-10k_20201231.htm?utm_source=openai)) Harvest’s main business lines included cannabis cultivation, product processing, branded product development, and retail dispensary operations. The company also built a branded portfolio that included names such as Alchemy, Avenue, Co2lors, loveli, Modern Flower, and Roll One, reflecting a strategy that combined premium products, value-oriented lines, and consumer-facing retail positioning. Geographically, Harvest operated in the United States, with activity referenced in states such as Arizona, Florida, Pennsylvania, Maryland, California, Arkansas, Massachusetts, and other regulated jurisdictions depending on the period and transaction history. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1754195/000119312522088625/d324481dex992.htm?utm_source=openai)) A defining corporate event was Trulieve Cannabis Corp.’s acquisition of Harvest, which closed on October 1, 2021. That transaction materially changed the standalone investment case for HRVSF, as the company ceased to function as an independent listed growth story and became mainly a legacy reference point within Trulieve’s broader integration history. In practical terms, investors now view HRVSF less as a live operating story and more as an acquisition-era cannabis asset with residual informational value tied to its historical footprint, brand portfolio, and integration into Trulieve. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1754195/000119312521361370/d276207dex993.htm?utm_source=openai))